Doolittle & Ganos Investment Counsel »

AstraZeneca shares owned by Doolittle & Ganos Investment Counsel

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Doolittle & Ganos Investment Counsel from 13F filings

Historical chart of Doolittle & Ganos Investment Counsel investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Doolittle & Ganos Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Doolittle & Ganos Investment Counsel

Quarter filed Position value Share count Share price at filing
2016-12-31 $5.0k 180 27.78

More positions owned by Doolittle & Ganos Investment Counsel

Templeton Emerging Markets Income Fund (TEI)
Templeton Global Income Fund (SABA)
SPDR DJ International Real Estate ETF (RWX)
Ubs Ag Jersey Brh Alerian Infrst
iShares FTSE EPRA/NAREIT Dev Gl Real ETF (IFGL)
SPDR Gold Trust (GLD)
Ares Capital Corporation (ARCC)
Chevron Corporation (CVX)
Apollo Investment
Apple (AAPL)
General Electric Company
Union Pacific Corporation (UNP)
Exxon Mobil Corporation (XOM)
Mortgage Reit Index real (REM)
iShares MSCI Emerging Markets Indx (EEM)

View all positions for Doolittle & Ganos Investment Counsel

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Holocene Advisors
Dimensional Fund Advisors
ClearBridge Advisors
Jpmorgan Chase & Co
WCM Investment Management
Wells Fargo & Company

View all funds holding AstraZeneca